Conviction
$ Value
$5.0M
Shares
3,184,713
Price
$2
Filed
Feb 4
▶ Why this score? (10/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $1.0M (+2)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ 10%+ owner (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
GOODMAN COREY S
Title
—
CIK
0001278411
Roles
Transaction Details
Transaction Date
2026-02-02
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
8,453,038
Footnotes
The shares are held of record by venBio Global Strategic Fund II, L.P. venBio Global Strategic GP II, LP is the sole general partner of venBio Global Strategic Fund II, LP and venBio Global Strategic GP II, Ltd. is the sole general partner of venBio Global Strategic GP II, L.P. The reporting person, a director of venBio Global Strategic GP II, Ltd., disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein. | The shares are held of record by venBio Global Strategic Fund, L.P. venBio Global Strategic GP, L.P. is the general partner of venBio Global Strategic Fund, L.P. and venBio Global Strategic GP, Ltd. is the general partner of venBio Global Strategic GP, L.P. The reporting person, a director of venBio Global Strategic GP, Ltd., disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein. | The shares are held of record by venBio SPV, LLC, which is wholly-owned by venBio Global Strategic Fund, L.P. The reporting person, a managing director of venBio SPV, LLC, disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein. | The shares are held of record by the Goodman Barinaga Trust for which the reporting person serves as trustee. | The shares are held of record by Emaldi Corporation for which the reporting person serves as a director. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.
Filing Info
Other Insiders at ALXO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Klencke Barbara
Chief Medical Officer
|
— | — | 2026-04-16 |
|
Lettmann Jason
CHIEF EXECUTIVE OFFICER
|
— | — | 2026-01-26 |
|
Pinto Shelly
SVP, FINANCE AND CAO
|
— | — | 2026-01-26 |
|
Knight Jeff E.
Chief Dev & Operating Officer
|
— | — | 2026-04-16 |
|
Shantharam Harish
Chief Financial Officer
|
— | — | 2026-01-26 |